AST to Platelet Ratio Index (APRI) for Predicting Fibrosis & Cirrhosis in Patient with Chronic Viral Hepatitis C (HCV)

Purpose: To evaluate a patient with chronic viral hepatitis C for fibrosis and cirrhosis using the AST to platelet ratio index (APRI) and other models of Wai et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with chronic viral hepatitis C?

Yes

Serum AST

Upper limit of serum AST

Platelet count

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

AST to platelet ratio index (APRI)

Which indicates that

Risk score for fibrosis

Risk score for cirrhosis

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
Laboratory Tests
Other Testing
Criteria For Diagnosis
Severity, Prognosis, Stage
Complications
- Criteria of Schoeniger-Hekele and Mueller for Using CA19-9 and CA125 to Diagnose Severe Liver Fibrosis in a Pateint with Noncholestatic Liver Disease

Therapy

Selection

Monitoring

Disease Progression

Specialty

Gastroenterology
Infectious Diseases

Objective

risk factors
laboratory tests
disease progression

ICD-10

B18.2 - Chronic viral hepatitis C
K74.0 - Hepatic fibrosis
K74.6 - Other and unspecified cirrhosis of liver

Info

Purpose: To evaluate a patient with chronic viral hepatitis C for fibrosis and cirrhosis using the AST to platelet ratio index (APRI) and other models of Wai et al.

Specialty: Gastroenterology, Infectious Diseases

Objective: risk factors, laboratory tests, disease progression

ICD-10: B18.2, K74.0, K74.6,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path